1. Home
  2. MRVI vs BVS Comparison

MRVI vs BVS Comparison

Compare MRVI & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • BVS
  • Stock Information
  • Founded
  • MRVI 2014
  • BVS 2011
  • Country
  • MRVI United States
  • BVS United States
  • Employees
  • MRVI N/A
  • BVS N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MRVI Health Care
  • BVS Health Care
  • Exchange
  • MRVI Nasdaq
  • BVS Nasdaq
  • Market Cap
  • MRVI 376.2M
  • BVS 448.8M
  • IPO Year
  • MRVI 2020
  • BVS 2021
  • Fundamental
  • Price
  • MRVI $3.34
  • BVS $6.64
  • Analyst Decision
  • MRVI Hold
  • BVS Strong Buy
  • Analyst Count
  • MRVI 9
  • BVS 5
  • Target Price
  • MRVI $4.54
  • BVS $14.40
  • AVG Volume (30 Days)
  • MRVI 1.4M
  • BVS 294.3K
  • Earning Date
  • MRVI 11-06-2025
  • BVS 11-04-2025
  • Dividend Yield
  • MRVI N/A
  • BVS N/A
  • EPS Growth
  • MRVI N/A
  • BVS N/A
  • EPS
  • MRVI N/A
  • BVS 0.03
  • Revenue
  • MRVI $219,830,000.00
  • BVS $564,142,000.00
  • Revenue This Year
  • MRVI N/A
  • BVS N/A
  • Revenue Next Year
  • MRVI $7.23
  • BVS $6.88
  • P/E Ratio
  • MRVI N/A
  • BVS $240.50
  • Revenue Growth
  • MRVI N/A
  • BVS 5.08
  • 52 Week Low
  • MRVI $1.67
  • BVS $5.81
  • 52 Week High
  • MRVI $8.54
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 69.44
  • BVS 42.20
  • Support Level
  • MRVI $2.94
  • BVS $6.46
  • Resistance Level
  • MRVI $3.30
  • BVS $7.14
  • Average True Range (ATR)
  • MRVI 0.20
  • BVS 0.26
  • MACD
  • MRVI 0.04
  • BVS -0.02
  • Stochastic Oscillator
  • MRVI 91.98
  • BVS 34.67

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: